{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:32:04Z","timestamp":1787632324582,"version":"build-2736575974"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>Nonexudative macular neovascularization (neMNV) is a risk factor for exudation in fellow eyes of patients with unilateral exudative age-related macular degeneration (AMD). Accurate estimation of prevalence of neMNV is required for sample size calculations for clinical trials evaluating novel interventions to delay exudation from neMNV. Certain dimensions of double-layer sign (DLS) on optical coherence tomography (OCT) are often regarded as a surrogate for neMNV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the prevalence of fellow-eye neMNV on OCT angiography (OCT-A) in eyes with AMD with DLS on OCT among patients with unilateral new-exudative AMD in the first eye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective observational cohort multicenter study took place in the United Kingdom from January 2021 through June 2025. The study included 862 participants with OCT and OCT-A within 3 months of initiation of anti\u2013vascular endothelial growth factor (VEGF) therapy, of whom 550 (63.8%) had both OCT and OCT-A performed within 30 days of the date of the first anti-VEGF injection to the fellow eye. These data were analyzed from July 2025 through October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN OUTCOMES AND MEASURES<\/jats:title>\n                    <jats:p>Prevalence of DLS, neMNV, and assessment of univariable and adjusted associations with neMNV and DLS were assessed using logistic regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Among 550 eyes (mean [SD] participant age, 78.0 [7.6] years; 315 female [57.3%] and 235 male [42.7%]), 112 (20.4%; 95% CI [Wilson score], 17.1%-24.0%) had DLS and 47 eyes (8.5%; 95% CI [Wilson score], 6.4%-11.3%) had neMNV at baseline, including 42 (89.36%) within DLS, 3 (6.4%) in fibrovascular irregular shallow\u2013pigment epithelial detachment, and 2 (4.3%) below drusen. Prevalence of neMNV was higher among eyes with thick DLS (n\u2009=\u200936 [48%]) compared with those with thin DLS (16.2%; n\u2009=\u20096; difference\u2009=\u2009\u221231.8%; 95% CI [Wilson score], \u221246.9% to \u221211.7%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS AND RELEVANCE<\/jats:title>\n                    <jats:p>While 1 in 5 fellow eyes had DLS on OCT among patients with unilateral new-onset exudative AMD in the first eye, the prevalence of neMNV on OCT-A was only 40% among these eyes with DLS. These results suggest DLS on OCT in fellow eyes of patients with new-onset exudative AMD in the first eye is not a good surrogate for neMNV<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ISRCTN registry Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN13798759?q=ISRCTN13798759&amp;amp;amp;filters=&amp;amp;amp;sort=&amp;amp;amp;offset=1&amp;amp;amp;totalResults=1&amp;amp;amp;page=1&amp;amp;amp;pageSize=10\">ISRTCTN13798759<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.0459","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:00:30Z","timestamp":1775746830000},"page":"405","source":"Crossref","is-referenced-by-count":2,"title":["Nonexudative Macular Neovascularization in Age-Related Macular Degeneration"],"prefix":"10.1001","volume":"144","author":[{"given":"Sridevi","family":"Thottarath","sequence":"first","affiliation":[{"name":"Moorfields Clinical Research Facility, NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarega","family":"Gurudas","sequence":"additional","affiliation":[{"name":"University College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Kubravi","sequence":"additional","affiliation":[{"name":"University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kazantzis","sequence":"additional","affiliation":[{"name":"Moorfields Clinical Research Facility, NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Merve","family":"Keskin","sequence":"additional","affiliation":[{"name":"Moorfields Clinical Research Facility, NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[{"name":"Moorfields Clinical Research Facility, NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EYENEON Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Burton","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Menon","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Chandran","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pearce","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Madhusudhan","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grabowska","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruque","family":"Ghanchi","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Talks","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gale","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"McKibbin","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kotagiri","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niro","family":"Narendran","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar","family":"Jafree","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Younis","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bailey","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Prakash","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Dinah","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Downey","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lottery","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paritosh","family":"Shah","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romi","family":"Chhabra","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Dhingra","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra","family":"Dias","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Freeman","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daren","family":"Hanumunthadu","sequence":"additional","affiliation":[{"name":"for the EYENEON Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"eoi260011r1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"8","key":"eoi260011r2","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jamaophthalmol.2019.1947","article-title":"Incidence of new choroidal neovascularization in fellow eyes of patients with age-related macular degeneration treated with intravitreal aflibercept or ranibizumab.","volume":"137","author":"Parikh","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"eoi260011r3","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.ophtha.2013.03.017","article-title":"Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.","volume":"120","author":"Maguire","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi260011r4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamaophthalmol.2018.2154","article-title":"Incidence of fellow eye involvement in patients with unilateral exudative age-related macular degeneration.","volume":"136","author":"Yanagi","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi260011r5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ajo.2010.01.007","article-title":"Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials.","volume":"149","author":"Barbazetto","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"eoi260011r6","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1167\/iovs.13-11665","article-title":"Functional characterization and multimodal imaging of treatment-naive \u201cquiescent\u201d choroidal neovascularization.","volume":"54","author":"Querques","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi260011r7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ophtha.2017.08.030","article-title":"Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography.","volume":"125","author":"de Oliveira Dias","year":"2018","journal-title":"Ophthalmology"},{"key":"eoi260011r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101113","article-title":"Towards a better understanding of non-exudative choroidal and macular neovascularization.","volume":"92","author":"Sacconi","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"eoi260011r9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/bjo.57.12.951","article-title":"New vessel formation beneath the retinal pigment epithelium in senile eyes.","volume":"57","author":"Sarks","year":"1973","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi260011r10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/tvst.7.5.19","article-title":"Prevalence of subclinical CNV and choriocapillaris nonperfusion in fellow eyes of unilateral exudative AMD on OCT angiography.","volume":"7","author":"Treister","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"7","key":"eoi260011r11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.oret.2020.02.016","article-title":"Nonexudative macular neovascularization\u2014a systematic review of prevalence, natural history, and recent insights from OCT angiography.","volume":"4","author":"Laiginhas","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"eoi260011r12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.oret.2019.03.008","article-title":"Detection of nonexudative choroidal neovascularization and progression to exudative choroidal neovascularization using OCT angiography.","volume":"3","author":"Bailey","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"eoi260011r13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3928\/23258160-20240125-01","article-title":"Fellow eyes conversion rates in patients with unilateral exudative age-related macular degeneration: an Academy IRIS Registry analysis.","volume":"55","author":"Gong","year":"2024","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"11","key":"eoi260011r14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/iovs.66.11.16","article-title":"Progression patterns in foveal-sparing geographic atrophy with double-layer sign due to neovascularization or basal laminar deposits.","volume":"66","author":"Fragiotta","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi260011r15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/iovs.63.1.20","article-title":"Local geographic atrophy growth rates not influenced by close proximity to non-exudative type 1 macular neovascularization.","volume":"63","author":"Trivizki","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"eoi260011r16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.63.11.4","article-title":"The fovea-protective impact of double-layer sign in eyes with foveal-sparing geographic atrophy and age-related macular degeneration.","volume":"63","author":"Fukuyama","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi260011r17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10792-024-03048-2","article-title":"Imaging characterization of the fellow eye in patients with unilateral polypoidal choroidal vasculopathy.","volume":"44","author":"Pereira","year":"2024","journal-title":"Int Ophthalmol"},{"issue":"5","key":"eoi260011r18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ophtha.2019.11.007","article-title":"Structural OCT signs suggestive of subclinical nonexudative macular neovascularization in eyes with large drusen.","volume":"127","author":"Narita","year":"2020","journal-title":"Ophthalmology"},{"key":"eoi260011r19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2022.09.018","article-title":"Optical coherence tomography biomarkers for conversion to exudative neovascular age-related macular degeneration.","volume":"247","author":"Wakatsuki","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi260011r20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.oret.2018.10.012","article-title":"Predictive value of the OCT double-layer sign for identifying subclinical neovascularization in age-related macular degeneration.","volume":"3","author":"Shi","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"eoi260011r21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.oret.2023.10.006","article-title":"The double layer sign is highly predictive of progression to exudation in age-related macular degeneration.","volume":"8","author":"Csincsik","year":"2024","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"eoi260011r22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.oret.2022.09.007","article-title":"OCT risk factors for development of atrophy in eyes with intermediate age-related macular degeneration.","volume":"7","author":"Hirabayashi","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"13","key":"eoi260011r23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/iovs.61.13.19","article-title":"Measuring the contributions of basal laminar deposit and Bruch\u2019s membrane in age-related macular degeneration.","volume":"61","author":"Sura","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi260011r24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ajo.2015.02.002","article-title":"Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization.","volume":"159","author":"Hage","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"eoi260011r25","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1038\/s41433-023-02460-9","article-title":"Study protocol on prevalence of non-exudative macular neovascularisation and its contribution to prediction of exudation in fellow eyes with unilateral exudative AMD (EYE-NEON).","volume":"37","author":"Thottarath","year":"2023","journal-title":"Eye (Lond)"},{"issue":"10","key":"eoi260011r26","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1167\/iovs.18-24624","article-title":"Classification of choroidal neovascularization using projection-resolved optical coherence tomographic angiography.","volume":"59","author":"Patel","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi260011r27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4.","volume":"127","author":"Guymer","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi260011r28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on oct: classification of Atrophy Report 3.","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi260011r29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/jamaophthalmol.2019.0868","article-title":"Imaging, genetic, and demographic factors associated with conversion to neovascular age-related macular degeneration: secondary analysis of a randomized clinical trial.","volume":"137","author":"Hallak","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"eoi260011r30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.ophtha.2019.05.016","article-title":"OCT risk factors for development of late age-related macular degeneration in the fellow eyes of patients enrolled in the HARBOR study.","volume":"126","author":"Nassisi","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi260011r31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/iovs.65.5.10","article-title":"Integrating machine learning and traditional survival analysis to identify key predictors of foveal involvement in geographic atrophy.","volume":"65","author":"Cicinelli","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2847245\/jamaophthalmology_thottarath_2026_oi_260011_1778698674.88498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:00:46Z","timestamp":1779375646000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2847245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.0459","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}